BG97851A - Hard dosed forms of almocalante and method for obtaining them - Google Patents

Hard dosed forms of almocalante and method for obtaining them

Info

Publication number
BG97851A
BG97851A BG97851A BG9785193A BG97851A BG 97851 A BG97851 A BG 97851A BG 97851 A BG97851 A BG 97851A BG 9785193 A BG9785193 A BG 9785193A BG 97851 A BG97851 A BG 97851A
Authority
BG
Bulgaria
Prior art keywords
almocalante
hard
obtaining
dosed forms
dosed
Prior art date
Application number
BG97851A
Other languages
Bulgarian (bg)
English (en)
Inventor
Kjell Andersson
Per Johan Lundberg
Roger Simonsson
Karin Wingstrand
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of BG97851A publication Critical patent/BG97851A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
BG97851A 1990-12-07 1993-06-04 Hard dosed forms of almocalante and method for obtaining them BG97851A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (sv) 1990-12-07 1990-12-07 Solid dosage forms of a drug
PCT/SE1991/000815 WO1992010172A1 (en) 1990-12-07 1991-12-03 Solid dosage forms of almokalant and processes for manufacture thereof

Publications (1)

Publication Number Publication Date
BG97851A true BG97851A (en) 1994-04-29

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97851A BG97851A (en) 1990-12-07 1993-06-04 Hard dosed forms of almocalante and method for obtaining them

Country Status (26)

Country Link
EP (1) EP0560821A1 (sh)
JP (1) JPH06503312A (sh)
CN (1) CN1063039A (sh)
AP (1) AP258A (sh)
AU (1) AU8930791A (sh)
BG (1) BG97851A (sh)
CA (1) CA2097178A1 (sh)
CZ (1) CZ103793A3 (sh)
FI (1) FI932554A (sh)
HU (1) HUT64217A (sh)
IE (1) IE914137A1 (sh)
IL (1) IL100150A0 (sh)
IS (1) IS3788A7 (sh)
LT (1) LTIP1717A (sh)
MA (1) MA22355A1 (sh)
MX (1) MX9102325A (sh)
MY (1) MY106776A (sh)
NZ (1) NZ240731A (sh)
PT (1) PT99719A (sh)
SE (1) SE9003902D0 (sh)
SK (1) SK55693A3 (sh)
TN (1) TNSN91117A1 (sh)
TW (1) TW215057B (sh)
WO (1) WO1992010172A1 (sh)
YU (1) YU186891A (sh)
ZA (1) ZA919264B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (de) 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (ja) * 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
SE8902236D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel polystyrenesulfonate

Also Published As

Publication number Publication date
SE9003902D0 (sv) 1990-12-07
YU186891A (sh) 1994-04-05
NZ240731A (en) 1993-10-26
MX9102325A (es) 1992-06-01
CZ103793A3 (en) 1994-02-16
SK55693A3 (en) 1993-10-06
AP258A (en) 1993-06-03
EP0560821A1 (en) 1993-09-22
PT99719A (pt) 1992-10-30
CN1063039A (zh) 1992-07-29
IL100150A0 (en) 1992-08-18
HU9301670D0 (en) 1993-09-28
AU8930791A (en) 1992-07-08
MA22355A1 (fr) 1992-07-01
IS3788A7 (is) 1992-06-08
TNSN91117A1 (fr) 1992-10-25
JPH06503312A (ja) 1994-04-14
WO1992010172A1 (en) 1992-06-25
TW215057B (sh) 1993-10-21
ZA919264B (en) 1992-08-26
LTIP1717A (en) 1995-07-25
CA2097178A1 (en) 1992-06-08
MY106776A (en) 1995-07-31
FI932554A (fi) 1993-06-08
HUT64217A (en) 1993-12-28
AP9100338A0 (en) 1992-01-31
FI932554A0 (fi) 1993-06-04
IE914137A1 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
IT7923395A0 (it) N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia.
IT7823092A0 (it) Corpo di carbonio in forma di una placca, e procedimento per la sua fabbricazione.
DE3772318D1 (de) Wenigschaeumende, alkalistabile, amphoterische, oberflaechenaktive mittel.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
NO891979D0 (no) Demonterbar spole.
IT7922420A0 (it) Apparecchiatura per pulire e/o disinfettare le cosiddette impugnature in equipaggiamenti per dentisti.
IT1207271B (it) Amminoglicosidi, procedimento per la loro preparazione e loro impiego.
IT7924575A0 (it) Strumento rilevatore, in particolare per protesi dentarie.
FI890994A0 (fi) Papperstillverkningsprocess omfattande tillsats av polyvinylaminer med hoeg molekylvikt till cellulosafiberuppslamningen i vaotpartiet.
FI912518A0 (fi) Modifiering av kaernan i superledande, en tennkaerna innehaollande materialer med en metallegering.
DE68923219D1 (de) Behandlung von Abfällen.
BG97851A (en) Hard dosed forms of almocalante and method for obtaining them
NO893892D0 (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
NO904894L (no) Forbindelsesledd mellom bestanddeler i forskjellige materialer.
DE3875192D1 (de) Abgasbehandlung.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
FI821324A0 (fi) Oxazolderivat
DE68922150D1 (de) Vorrichtung zur elektrochemischen Behandlung.
NO865246D0 (no) Haarskyllemiddel som gir toerrhetsfoelelse og sterk glans.
IT8720707A0 (it) Impiego del 2,4-monofurfuriliden-sorbitolo ad uso cosmetico.
DK53779A (da) 1,1-disubstituerede ocahydro-indolo (2,3-a)-quinoliziner deres fremstilling og anvendelse
DE68904322D1 (de) Einrichtung zur behandlung von gasen.
IT8420528A0 (it) Difenilazometine idrossilate, loro preparazione e loro impiego in terapeutica.
IT8420527A0 (it) Difenilazometine sostituite, loro preparazione e loro impiego in terapeutica.
IT7922320A0 (it) 1,6-dimesil-3,4-dimetil-d-mannitolo e procedimento per la sua preparazione.